K Gao, R Wang, J Chen, L Cheng, J Frishcosy… - Chemical …, 2022 - ACS Publications
Despite tremendous efforts in the past two years, our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …
E King, E Aitchison, H Li, R Luo - Frontiers in Molecular Biosciences, 2021 - frontiersin.org
The grand challenge in structure-based drug design is achieving accurate prediction of binding free energies. Molecular dynamics (MD) simulations enable modeling of …
Epstein–Barr virus (EBV), a known tumorigenic virus, is associated with various neuropathies, including multiple sclerosis (MS). However, there is no anti-EBV FDA …
NA Jonniya, MF Sk, P Kar - Physical Chemistry Chemical Physics, 2021 - pubs.rsc.org
The With-No-Lysine (WNK) kinase plays a significant role in controlling blood pressure and body fluid homeostasis. Consequently, WNK1 is considered a potential target for treating …
Background Multiple sclerosis (MS) can be induced upon successful presentation of myelin antigens by MHC I/II. Antigenic similarity between the myelin and viral proteins may worsen …
Rheumatoid arthritis (RA) is a chronic immune-related condition, primarily of joints, and is highly disabling and painful. The inhibition of Janus kinase (JAK)-related cytokine signaling …
The SARS-CoV-2 non-structural protein (nsp) nsp10–nsp16 complex is essential for the 2′- O-methylation of viral mRNA, a crucial step for evading the innate immune system, and it is …
Currently, no antiviral drug or vaccine is available to treat COVID-19 caused by SARS-CoV- 2. This underscores an urgent need for developing a drug against SARS-CoV-2. The main …
VH Masand, MF Sk, P Kar, V Rastija… - … and intelligent laboratory …, 2021 - Elsevier
SARS-CoV-2 has rapidly emerged as a global pandemic with high infection rate. At present, there is no drug available for this deadly disease. Recently, M pro (Main Protease) enzyme …